Release Date: 27/01/10 18:31 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 97.19KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%